Glyxambi®(empagliflozin / linagliptin) | Steglatro®(ertugliflozin) |
---|---|
Prescription Only | Prescription Only |
Dosage & Administration | |
Administration | |
Dosing | |
Latin Shorthand | |
Financial Assistance | |
Out-Of-Pocket Costs With Copay Card | |
$10. Learn more. | $0. Learn more. |
Annual Cap | |
$175 per month. Learn more. | $583 per fill . Learn more. |
Assistance Expiration | |
12 uses. Learn more. | |
Generics | |
No lower-cost generic available | No lower-cost generic available |
Physician Advisory | |
Adverse Reactions | |
Most common adverse reactions (5% or greater incidence) were urinary tract
infections, nasopharyngitis, and upper respiratory tract infections.. Learn more. | Most common adverse reactions (incidence ≥ 5%) were female genital
mycotic infections. . Learn more. |
Mechanism of Actions (MoA) | |
SGLT2 Inhibitors. Learn more. | SGLT2 Inhibitors. Learn more. |
Special Populations | |